Work

4P Independent validation of the PAM50-based chemoendocrine score (CES) as pathologic complete response (pCR) and disease-free survival (DFS) predictor in hormone receptor (HR)+/HER2+ breast cancer (BC)

Year: 2020

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.03.140

Authors: T. Pascual, A. Fernandez-Martinez, M. Tanioka, M.V. Dieci, S. Pernas Simon, J. Gavila Gregori, V. Guarneri, J. Cortés, P. Villagrasa, M.J. Vidal, B. Adamo, M. Muñoz, G. Griguolo, A. Llombart Cussac, M. Oliveira, L. Paré, L.A. Carey, C.M. Perou, A. Prat

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Istituto Oncologico Veneto, Institut Català d'Oncologia, Fundación Instituto Valenciano de Oncología, Solti, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Arnau de Vilanova, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3026100261

FWCI: 0.072

Cites:

Cited by: 1

Related to: 10